The effect of cyclosporin A on alveolar bone in rats subjected to experimental periodontal disease

Toxicologic Pathology

Volumn 34, Issue 6, 2006, Pages 716-722

  Cetinkaya, Burcu Ozkan ^a   Acikgoz, Gokhan ^a   Keles, Gonca Cayir ^a   Ayas, Bulent ^a   Korkmaz, Adnan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Adverse effects; Alveolar bone; Cyclosporine A; Periodontal disease; Rats

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; BONE DEVELOPMENT; DISEASE MODEL; DRUG EFFECT; HOMEOSTASIS; JAW DISEASE; MALE; MOLAR TOOTH; NONPARAMETRIC TEST; OSTEOLYSIS; PATHOLOGY; PERIODONTAL DISEASE; RADIOGRAPHY; RAT; TIME; TOOTH RADIOGRAPHY; WISTAR RAT;

ALKALINE PHOSPHATASE; ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CYCLOSPORINE; DISEASE MODELS, ANIMAL; HOMEOSTASIS; IMMUNOSUPPRESSIVE AGENTS; MALE; MANDIBULAR DISEASES; MOLAR; OSTEOGENESIS; PERIODONTAL DISEASES; RADIOGRAPHY, DENTAL; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 34347357205     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230600826269     Document Type: Article

References (44)

1. Adams, D., and Davies, G. (1984). Gingival hyperplasia associated with cyclosporin A. A report of two cases. Br Dent J 157, 89-90.
2. Bartold, P. M. (1989). Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodontal Res 24, 314-21.
3. Bunjes, D., Hardt, C., Rollinghoff, M., and Wagner, H. (1981). Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 11, 657-61. (Pubitemid 11057615)
4. Calne, R. Y., Rolles, K., White, D. J., Thiru, S., Evans, D. B., McMaster, P., Dunn, D. C., Craddock, G. N., Henderson, R. G., Aziz, S., and Lewis, P. (1979). Cyclosporin A initially as the only immunosupresant 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 2, 1033-6. (Pubitemid 10213970)
5. Canalis, E., McCarthy, T., and Centrella, M. (1988). Growth factors and the regulation of bone remodeling. J Clin Invest 81, 277-81. (Pubitemid 18075217)
6. Cetinkaya, B. O., Acikgoz, G., Ayas, B., Aliyev, E., and Sakallioglu, E. E. (2006a). Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats. J Periodontol 77, 54-60. (Pubitemid 43949657)
7. Cetinkaya, B. O., Acikgoz, G., Aydin, O., Korkmaz, A., and Keles, G. C. (2006b). The relationship between Proliferating Cell Nuclear Antigen expression and histomorphometrical alterations in cyclosporin A-induced gingival overgrowth in rats. Toxicol Pathol 34, 180-6.
8. Cox D. S., Williams-Miller C., and Nadip, T. (1987). Role of interleukin-2 in periodontal bone loss in the ligated rats. J Periodontol 58, 130.
9. Cueto-Manzano, A. M., Konel, S., Hutchison, A. J., Crowley, V., France, M. W., Freemont, A. J., Adams, J. E., Mawer, B., and Gokal, R. (1999). Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int 55, 2021-9. (Pubitemid 29197992)
10. Daley, T. D., and Wysocki, G. P. (1984). Cyclosporine therapy. Its significance to the periodontist. J Periodontol 55, 708-12. (Pubitemid 15152387)
11. Dieperink, H., Kemp, E., Leyssac, P. P., and Starklint, H. (1986). Cyclosporine A: effectiveness and toxicity in a rat model. Clin Nephrol 25, 46-50.
12. Dougados, M., Awada, H., and Amor, B. (1988). Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis 47, 127-33. (Pubitemid 18046617)
13. Esa, A. H., Paxman, D. G., Noga, S. J., and Hess, A. D. (1988). Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation. Transplant Proc 20, 80-6.
14. Faulds, D., Goa, K. L., and Benfield, P. (1993). Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45, 953-1040. (Pubitemid 23219075)
15. Fischer, R. G., and Klinge, B. (1994). Clinical and histological evaluation of ligature-induced periodontal breakdown in domestic ferrets immunosuppressed by cyclosporin-A. J Clin Periodontol 21, 240-9.
16. Fu, E., Hsieh, Y. D., Nieh, S., Wikesjo, U. M., and Liu, D. (1999). Effects of cyclosporin A on alveolar bone: an experimental study in the rat. J Periodontol 70, 189-94. (Pubitemid 29140480)
17. Gemmell, E., Marshall, R. I., and Seymour, G. J. (1997). Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 14, 112-43. (Pubitemid 127601173)
18. Goncalves, P. F., Filho, G. R., Sallum, E. A., Sallum, A. W., and Nociti Junior, F. H. (2003). Immunosuppressant therapy and bone loss in ligature-induced periodontitis - a study in rats. Pesqui Odontol Bras 17, 46-50.
19. Howard, C. V., and Reed, M. G. (1998). Estimation of component volume and volume fraction. In Unbiased Stereology, Three Dimensional Measurement in Microscopy (C. V. Howard, and M. G. Reed, eds.), Chapter 4, pp. 55-68. First edition, BİOS Scientific Publishers, Oxford, UK.
20. Iacopino, A. M., Doxey, D., Cutler, C. W., Nares, S., Stoever, K., Fojt, J., Gonzales, A., and Dill, R. E. (1997). Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 68, 73-83.
21. Keles, G. C., Acikgoz, G., Ayas, B., Sakallioglu, E., and Firatli, E. (2005). Determination of systemically and locally induced periodontal defects in rats. Indian J Med Res 121, 176-84. (Pubitemid 40528740)
22. Kelly, G. P., Cain, R. J., Knowles, J. W., Nissle, R. R., Burgett, F. G., Shick, R. A., and Ramfjord, S. P. (1975). Radiographs in clinical periodontal trials. J Periodontol 46, 381-6.
23. Keown, P. A., and Stiller, C. R. (1987). Cyclosporine: a double-edged sword. Hosp Pract 22, 219-20.
24. Klaushofer, K., Hoffmann, O., Stewart, P. J., Czerwenka, E., Koller, K., Peterlik, M., and Stern, P.H. (1987). Cyclosporine A inhibits bone resorption in cultured neonatal mouse calvaria. J Pharmacol Exp Ther 243, 584-90. (Pubitemid 18011543)
25. Klein, L., Li, Q. X., Donovan, C. A., and Powell, A. E. (1990). Variation of resorption rates in vivo of various bones in immature rats. Bone Miner 8, 169-75. (Pubitemid 20045581)
26. Korkmaz, A., Ayas, B., Çiftçi, N., and Tümkaya, L. (2003). A novel systemic field sampling approach for relatively large reference spaces used in neurostereological studies. Neuroanatomy, 2 (Abstracts Book), 20P.
27. Mason, J. (1990). Renal side-effects of cyclosporin A. Br J Dermatol 122, 71-7.
28. McCauley, L. K., Rosol, T. J., and Capen, C. C. (1992). Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitro. Calcif Tissue Int 51, 291-7.
29. Movsowitz, C., Epstein, S., Fallon, M., Ismail, F., and Thomas, S. (1988). Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123, 2571-7.
30. Muchmore, J. S., Cooper, D. K., Ye, Y., Schlegel, V. T., and Zuhdi, N. (1991). Loss of vertebral bone density in heart transplant patients. Transplant Proc 23, 1184-5.
31. Nassar, C. A., Nassar, P. O., Abi Rached, R. S., Holzhausen, M., Marcantonio Jr, E., and Spolidorio, L. C. (2004). Effect of cyclosporin A on alveolar bone homeostasis in a rat periodontitis model. J Periodontal Res 39, 143-8. (Pubitemid 38692082)
32. Okada, H., Kida, T., and Yamagami, H. (1982). Characterization of the immunocompetent cells in human advanced periodontitis. J Periodont Res 17, 472-3. (Pubitemid 13166457)
33. Orcel, P., Bielakoff, J., Modrowski, D., Miravet, L., and de Vernejoul, M. C. (1989). Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res 4, 387-91. (Pubitemid 19162007)
34. Schincaglia, G. P., Forniti, F., Cavallini, R., Piva, R., Calura, G., and del Senno, L. (1992). Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 21, 181-5.
35. Seymour, R. A., Ellis, J. S., and Thomason, J. M. (2000). Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 27, 217-23.
36. Seymour, R. A., Smith, D. G., and Rogers, S. R. (1987). The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 14, 610-3.
37. Shen, E. C., Fu, E., and Hsieh, Y. D. (2001). Effects of cyclosporin A on dental alveolar bone: a histomorphometric study in rats. J Periodontol 72, 659-65.
38. Somacarrera, M. L., Hernandez, G., Acero, J., and Moskow, B. S. (1994) Localization of gingival overgrowth in heart transplant patients undergoing cyclosporin therapy. J Periodontol 65, 666-70. (Pubitemid 24236700)
39. Spolidorio, L. C., Spolidorio, D. M., and Holzhausen, M. (2004). Effects of long-term cyclosporin therapy on the periodontium of rats. J Periodontal Res 39, 257-62. (Pubitemid 38969609)
40. Tollefsen, T., Koppang, H. S., and Messelt, E. (1982). Immunosuppression and periodontal disease in man. Histological and ultrastructural observations. J Periodontal Res 17, 329-44. (Pubitemid 13239270)
41. Wassef, R., Cohen, Z., and Langer, B. (1985). Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage. Transplantation 40, 489-93. (Pubitemid 16196198)
42. Whisler, R. L., Lindsey, J. A., Proctor, K. V., Morisaki, N., and Cornwell, D.G. (1984). Characteristics of cyclosporine induction of increased prostaglandin levels from human peripheral blood monocytes. Transplantation 38, 377-81. (Pubitemid 14023169)
43. Wilmink, J. M., Bras, J., Surachno, S., van Heyst, J. L., and van der Horst, J. M. (1989). Bone repair in cyclosporin treated renal transplant patients. Transplant Proc 21, 1492-4. (Pubitemid 19130918)
44. Wong, M. M., Rao, L. G., Ly, H., Hamilton, L., Tong, J., Sturtridge, W., McBroom, R., Aubin, J. E., and Murray, T. M. (1990). Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res 5, 803-13. (Pubitemid 20294764)